Rheumatoid Arthritis Diagnostic Tests Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Rheumatoid Arthritis is an autoimmune disease which leads joint pain due to inflammation of joint lining. The condition usually affects the hands, feet and wrists. Blood tests commonly used to diagnose RA include, rheumatoid factor anti-cyclic citrullinated peptide, C - reactive protein (CRP), and Erythrocyte Sedimentation Rate (ESR). Increasing prevalence of RA is expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period. Furthermore, development of new blood tests for RA is also expected to propel growth of the global rheumatoid arthritis diagnostic tests market over the forecast period

Key features of the study:

• This report provides in-depth analysis of the Rheumatoid Arthritis Diagnostic Tests market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global Rheumatoid Arthritis Diagnostic Tests market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global Rheumatoid Arthritis Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market

Detailed Segmentation:

Rheumatoid Arthritis Diagnostic Tests Market, By Test Type:

• Serology Test
• Erythrocyte Sedimentation Rate (ESR)
• Rheumatoid Factor (RF)
• Anti-cyclic Citrullinated Peptide (anti-CCP)
• Antinuclear Antibody (ANA)
• Uric Acid
• Other Tests
• Monitoring RA Treatment Efficiency Tests
• Salicylate Level Count
• Muscle Enzyme Tests (CPK, Aldolase)
• Creatinine Test

Rheumatoid Arthritis Diagnostic Tests Market, By End User:

• Diagnostic Laboratories
• Private Laboratories
• Public Laboratories
• Ambulatory Surgical Centers

Rheumatoid Arthritis Diagnostic Tests Market, By Region:

• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region
• South Africa
• Central Africa
• North Africa

Company Profiles

• Abbott Diagnostics (Abbott Laboratories) *
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
• Antibodies Inc.
• Beckman Coulter, Inc.
• Euro Diagnostica AB
• F. Hoffmann-La Roche Ltd.
• Qiagen NV
• Siemens Healthcare Gmb
• Thermo Fisher Scientific Inc.
• “*” marked represents similar segmentation in other categories in the respective section.